TERN - Terns Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$53.00
DETAILS
HIGH:
$53.00
LOW:
$53.00
MEDIAN:
$53.00
CONSENSUS:
$53.00
UPSIDE:
0.09%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 0 | $0 | -- | -201,191 | SOLD |
| Soros | 0 | $0 | -- | -321,905 | SOLD |
| Greenblatt | 0 | $0 | -- | -16,497 | SOLD |
| Wood | 0 | $0 | -- | -4,300 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-05 | FELLOWS DAVID A | director | D-Return | 22,000 | $10.72 | $236K |
| 2026-05-05 | KINDLER JEFFREY B | director | D-Return | 45,000 | $4.10 | $184K |
| 2026-05-05 | KINDLER JEFFREY B | director | D-Return | 10,657 | $4.46 | $48K |
| 2026-05-05 | Azelby Robert | director | D-Return | 90,000 | $4.13 | $372K |
| 2026-05-05 | Turner Heather D | director | D-Return | 45,000 | $4.10 | $184K |
| 2026-05-05 | Turner Heather D | director | D-Return | 1,697 | $34.60 | $59K |
| 2026-05-05 | Burroughs Amy L. | director, officer: Chief Executive Officer | U-Tender | 8,319 | $53.00 | $441K |
| 2026-05-05 | Tripuraneni Radhika | director | D-Return | 4,676 | $6.85 | $32K |
| 2026-05-05 | FELLOWS DAVID A | director | D-Return | 2,828 | $34.60 | $98K |
| 2026-05-05 | KINDLER JEFFREY B | director | D-Return | 4,676 | $6.85 | $32K |
| 2026-05-05 | KINDLER JEFFREY B | director | D-Return | 28,475 | $9.24 | $263K |
| 2026-05-05 | KINDLER JEFFREY B | director | D-Return | 22,000 | $10.72 | $236K |
| 2026-05-05 | KINDLER JEFFREY B | director | D-Return | 1,697 | $34.60 | $59K |
| 2026-05-05 | FELLOWS DAVID A | director | D-Return | 18,650 | $4.46 | $83K |
| 2026-05-05 | FELLOWS DAVID A | director | D-Return | 28,475 | $9.24 | $263K |
| 2026-05-05 | FELLOWS DAVID A | director | D-Return | 32,000 | $12.05 | $386K |
| 2026-05-05 | Tripuraneni Radhika | director | D-Return | 32,000 | $12.05 | $386K |
| 2026-05-05 | FELLOWS DAVID A | director | D-Return | 45,000 | $4.10 | $184K |
| 2026-05-05 | Azelby Robert | director | D-Return | 1,697 | $34.60 | $59K |
| 2026-05-05 | Tripuraneni Radhika | director | D-Return | 64,000 | $2.13 | $136K |
| 2026-05-05 | Tripuraneni Radhika | director | D-Return | 45,000 | $4.10 | $184K |
| 2026-05-05 | Tripuraneni Radhika | director | D-Return | 10,657 | $4.46 | $48K |
| 2026-05-05 | Gengos Andrew | officer: Chief Financial Officer | D-Return | 137,500 | $37.18 | $5.1M |
| 2026-05-05 | Kuriakose Emil | officer: Chief Medical Officer | D-Return | 485,000 | $4.64 | $2.3M |
| 2026-05-05 | Kuriakose Emil | officer: Chief Medical Officer | D-Return | 117,500 | $5.46 | $642K |